Skip to main
IPX

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd has seen an increase in its 2029 EBITDA multiple from 7x to 8x, highlighting the company's progress and growth potential. The acquisition of 290 tonnes of titanium scrap at no cost is positioned to enhance margins for the next 18 months, reflecting a strategic advantage in production efficiency. Furthermore, IperionX is well-positioned for rapid capacity expansion and revenue growth, indicating a robust outlook for the company’s valuation as its operational capabilities enhance.

Bears say

IperionX Ltd faces substantial risks associated with commodity price fluctuations, which can significantly impact its financial stability and profitability. The company may encounter operational and technical challenges, including potential permitting or construction delays, which could hinder its ability to meet production cost expectations and result in capital overruns. Furthermore, IperionX's ability to gain market share may be compromised by unforeseen events or unanticipated dilutive financial transactions, raising further concerns about its long-term financial outlook.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.